Antimicrobial Use during the SARS-CoV-2 Pandemic in a Greek Tertiary University Hospital

In cases of SARS-CoV-2 hospitalization, despite low bacterial co-infection rates, antimicrobial use may be disproportionately high. Our aim was to quantify such usage in COVID-19 patients and identify factors linked to increased antibiotic use. We retrospectively studied patients with SARS-CoV-2 inf...

Full description

Saved in:
Bibliographic Details
Published inMicroorganisms (Basel) Vol. 12; no. 3; p. 623
Main Authors Biros, Dimitrios, Filippas-Ntekouan, Sempastian, Limperatou, Diamantina, Liontos, Angelos, Matzaras, Rafail, Tsarapatsani, Konstantina-Helen, Kolios, Nikolaos-Gavriel, Pappa, Christiana, Nasiou, Maria, Pargana, Eleni, Tsiakas, Ilias, Samanidou, Valentini, Athanasiou, Lazaros, Konstantopoulou, Revekka, Milionis, Haralampos, Christaki, Eirini
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.03.2024
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In cases of SARS-CoV-2 hospitalization, despite low bacterial co-infection rates, antimicrobial use may be disproportionately high. Our aim was to quantify such usage in COVID-19 patients and identify factors linked to increased antibiotic use. We retrospectively studied patients with SARS-CoV-2 infection who were hospitalized at our institution during the pandemic. In the initial two waves of the pandemic, antimicrobial use was notably high (89% in the first wave and 92% in the second), but it decreased in subsequent waves. Elevated procalcitonin (>0.5 μg/mL) and C-reactive protein (>100 mg/L) levels were linked to antibiotic usage, while prior vaccination reduced antibiotic incidence. Antimicrobial use decreased in the pandemic, suggesting enhanced comprehension of SARS-CoV-2's natural course. Additionally, it was correlated with heightened SARS-CoV-2 severity, elevated procalcitonin, and C-reactive protein levels.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2076-2607
2076-2607
DOI:10.3390/microorganisms12030623